How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

Architecture delivery. The stories were vehicles; the real payload was a way of organizing experience into causal, moral, and ...

As AI transforms education, we must redefine intelligence beyond biological limits and embrace cognitive functions across ...

Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...

The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...

In the science of artificial intelligence (AI), there is a concept called technological singularity. It is the most dangerous level of AI, of technology and indeed, of science itself, for a number of ...

Dune Part Three science gets graded against real biology and physics as the December 18 film’s new IMAX trailer drops: somatic cell nuclear transfer already clones primates, Gödel’s incompleteness ...

Most research papers assume a human will read them first. However, Google DeepMind's latest sprawling 60-page look at the road from AGI to superintelligence doesn't bother with that pretense. Section ...

The loop takes agentic AI a step further, by authorizing a swarm of agents to work continuously in the background, endlessly.

At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...